Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
Singh
S
S
D000279:Administration, Cutaneous; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016001:Confidence Intervals; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011565:Psoriasis / Q000188:drug therapy*; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D014677:Pharmaceutical Vehicles; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone